← Back to Patent Explorer
US3856769A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for preparing biologically active (pyro) glutamyl-histidyl-tryptophyl-seryl-tyrosyl-glycyl-leucyl-arginyl-prolyl-glycine amide

Assignee: Individual
•
Filing: 1972-09-05
•
Granted: 1974-12-24
•
Expires: 1992-09-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for preparing (pyro)glutamyl-histidyl-tryptophylseryltyrosyl-glycyl-leucyl-arginyl-prolyl -glycine amide which comprises reacting an oligopeptide fragment identified as (I) with an oligopeptide fragment identified as (II), each of which are prepared according to the synthesis described below, to form the heptapeptide, seryl-tyroxyl-glycyl-leucyl-arginyl-prolylglycine amide having some corresponding protective groups thereon, and coupling the resulting heptapeptide with protected tryptophane, histidine and (pyro)glutamic acid in turn at the nitrogen terminal of the each resulting peptide by stepwise elongation to result in a protected decapeptide, and then removing all the protective groups by treating the protected decapeptide with hydrogen fluoride: Fragment (I) Leucyl-(N-protected)arginyl-prolyl-glycineamide is prepared by coupling protected arginine with proline whose carboxyl group is protected, to produce arginyl-proline, coupling glycine amide with the resulted arginyl-proline to produce arginyl-prolylglycine amide and further coupling leucine with the Alpha nitrogen terminal of the resulting tripeptide and then removing only the protective group on the nitrogen terminal of the leucine portion, and Fragment (II) (N- and O-protected)seryl-(O-protected)tyrosyl-glycine is prepared by coupling a lower alkyl ester of glycine to result in a corresponding seryl-tyrosyl-glycine lower alkyl ester and hydrolyzing only the ester bond of the tripeptide, thus formed.

Inventors

  • 👤 S Sakakibara
  • 👤 Y Kumahara
  • 👤 T Kimura

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 04:45
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/10; C07K5/1002; C07K5/1005; C07K7/00; C07K7/04; C07K7/23; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/11; Y10S930/13

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 188 words
A METHOD FOR PREPARING BIOLOGICALLY ACTIVE (PYRO)GLUTAMYL-HISTIDYL-TRYPTOPHYI-SERYL-TYROSYL-GLYCYL-LEUCYL-ARGINYLPROLYL-GLYCINE AMIDE WHICH COMPRISES REACTING AN OLIGOPEPTIDE FRAGMENT IDENTIFIED AS (I) WITH AN OLIGOPEPTIDE FRAGMENT IDENTIFIED AS (II), EACH OF WHICH ARE PREPARED ACCORDING TO THE SYNTHESIS DESCRIBED BELOW, TO FORM THE HEPTAPEPTIDE, SERYLTRYROSYL-GLYCYL-LEUCYL-ARGINYL-PROLYL-GLYCINE AMIDE HAVING SOME CORRESPONDING PROTECTIVE GROUPS THEREON, AND COUPLING THE RESULTING HEPTAPEPTIDE WITH PROTECTED TRYPTOPHANE, HISTIDINE AND (PYRO)GLUTAMIC ACID IN TURN AT THE NITROGEN TERMINAL OF THE EACH RESULTING PEPTIDE BY STEPWISE ELONGATION TO RESULT IN A PROTECTED DECAPEPTIDE, AND THEN REMOVING ALL THE PROTECTIVE GROUPS BY TREATING THE PROTECTED DECAPEPTIDE WITH HYDROGEN FLUORIDE: FRAGMENT (I): LEUCYL-(N-PROTECTED)ARGINYL-PROLYL-GLYCINEAMIDE IS PREPARED BY COUPLING PROTECTED ARGININE WITH PROLINE WHOSE CARBOXYL GROUP IS PROTECTED, TO PRODUCE ARGINYLPROLINE, COUPLING GLYCINE AMIDE WITH THE RESULTED ARGINYL-PROLINE TO PRODUCE ARGINYL-PROLYL-GLYCINE AMIDE AND FURTHER COUPLING LEUCINE WITH THE A-NITROGEN TERMINAL OF THE RESULTING TRIPEPTIDE AND THEN REMOVING ONLY THE PROTECTIVE GROUP ON THE NITROGEN TERMINAL OF THE LEUCINE PORTION, AND FRAGMENT (II): (N- AND 0-PROTECTED)SERYL-(O-PROTECTED) TROSYL-GLYCINE IS PREPARED BY COUPLING A LOER ALKYL ESTER OF GLYCINE TO RESULT IN A CORRESPONDING SERYL-TYROSYL-GLYCINE LOWER ALKYL ESTER AND HYDROLYZING ONLY THE ESTER BOND OF THE TRIPEPTIDE, THUS FORMED.
Claim 2
Independent Claim 188 words
A METHOD FOR PREPARING BIOLOGICALLY ACTIVE (PYRO)GLUTAMYL-HISTIDYL-TRYPTOPHYI-SERYL-TYROSYL-GLYCYL-LEUCYL-ARGINYLPROLYL-GLYCINE AMIDE WHICH COMPRISES REACTING AN OLIGOPEPTIDE FRAGMENT IDENTIFIED AS (I) WITH AN OLIGOPEPTIDE FRAGMENT IDENTIFIED AS (II), EACH OF WHICH ARE PREPARED ACCORDING TO THE SYNTHESIS DESCRIBED BELOW, TO FORM THE HEPTAPEPTIDE, SERYLTRYROSYL-GLYCYL-LEUCYL-ARGINYL-PROLYL-GLYCINE AMIDE HAVING SOME CORRESPONDING PROTECTIVE GROUPS THEREON, AND COUPLING THE RESULTING HEPTAPEPTIDE WITH PROTECTED TRYPTOPHANE, HISTIDINE AND (PYRO)GLUTAMIC ACID IN TURN AT THE NITROGEN TERMINAL OF THE EACH RESULTING PEPTIDE BY STEPWISE ELONGATION TO RESULT IN A PROTECTED DECAPEPTIDE, AND THEN REMOVING ALL THE PROTECTIVE GROUPS BY TREATING THE PROTECTED DECAPEPTIDE WITH HYDROGEN FLUORIDE: FRAGMENT (I): LEUCYL-(N-PROTECTED)ARGINYL-PROLYL-GLYCINEAMIDE IS PREPARED BY COUPLING PROTECTED ARGININE WITH PROLINE WHOSE CARBOXYL GROUP IS PROTECTED, TO PRODUCE ARGINYLPROLINE, COUPLING GLYCINE AMIDE WITH THE RESULTED ARGINYL-PROLINE TO PRODUCE ARGINYL-PROLYL-GLYCINE AMIDE AND FURTHER COUPLING LEUCINE WITH THE A-NITROGEN TERMINAL OF THE RESULTING TRIPEPTIDE AND THEN REMOVING ONLY THE PROTECTIVE GROUP ON THE NITROGEN TERMINAL OF THE LEUCINE PORTION, AND FRAGMENT (II): (N- AND 0-PROTECTED)SERYL-(O-PROTECTED) TROSYL-GLYCINE IS PREPARED BY COUPLING A LOER ALKYL ESTER OF GLYCINE TO RESULT IN A CORRESPONDING SERYL-TYROSYL-GLYCINE LOWER ALKYL ESTER AND HYDROLYZING ONLY THE ESTER BOND OF THE TRIPEPTIDE, THUS FORMED.

References Cited (Backward Citations)

US3784535A Cited
US3780014A Cited
US3790554A Cited
US3787386A Cited
US3803117A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-12-23 1978-06-24 1978-12-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-12-23 1982-06-24 1982-12-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-12-23 1986-06-24 1986-12-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag